InvestSMART

Althea Group Holdings Limited (ASX: AGH) - Announcements

Current share price for AGH : $0.020 0.001 (4.76%)+

ASX company news and announcements for Althea Group Holdings Limited (AGH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Althea Group Holdings Limited (AGH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Althea Group Holdings Limited (AGH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Althea Group Holdings Limited (AGH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Althea Passes 3,000 Patient Milestone 15 Nov 2019 8:20AM $0.470 $0.020 fallen by 95.74%
- MyAccess Clinics Secures Licence with UK Health Regulator 14 Nov 2019 8:24AM $0.475 $0.020 fallen by 95.79%
- Althea to Supply Product for Clinical Trial 13 Nov 2019 8:29AM $0.475 $0.020 fallen by 95.79%
- Althea Commences German Market Entry 12 Nov 2019 8:24AM $0.435 $0.020 fallen by 95.40%
- Notice of Annual General Meeting/Proxy Form 30 Oct 2019 3:32PM $0.380 $0.020 fallen by 94.74%
- Becoming a substantial holder from PDL 29 Oct 2019 4:47PM $0.395 $0.020 fallen by 94.94%
- Althea Launches New Full Spectrum CBD Product 28 Oct 2019 8:16AM $0.400 $0.020 fallen by 95%
- Change in substantial holding 28 Oct 2019 8:13AM $0.400 $0.020 fallen by 95%
- Change of Director's Interest Notice 25 Oct 2019 10:20AM $0.455 $0.020 fallen by 95.60%
- Change of Director's Interest Notice 25 Oct 2019 10:17AM $0.435 $0.020 fallen by 95.40%
- Change of Director's Interest Notice 25 Oct 2019 10:16AM $0.435 $0.020 fallen by 95.40%
- Althea Extends Product Supply Agreement Until 2027 25 Oct 2019 9:12AM $0.525 $0.020 fallen by 96.19%
- Trading Halt 23 Oct 2019 10:39AM $0.525 $0.020 fallen by 96.19%
- Pause in Trading 23 Oct 2019 10:33AM $0.525 $0.020 fallen by 96.19%
- Change of Director's Interest Notice 22 Oct 2019 5:48PM $0.540 $0.020 fallen by 96.30%
- Change of Director's Interest Notice 22 Oct 2019 5:48PM $0.540 $0.020 fallen by 96.30%
- Appendix 3B 22 Oct 2019 5:44PM $0.540 $0.020 fallen by 96.30%
- Cleansing Notice 22 Oct 2019 5:42PM $0.540 $0.020 fallen by 96.30%
- Althea Completes Acquisition of Peak Processing Solutions 18 Oct 2019 9:41AM $0.635 $0.020 fallen by 96.85%
- Appendix 4C, Market Update and Peak Processing LOI 16 Oct 2019 8:45AM $0.635 $0.020 fallen by 96.85%
- Results of Meeting 14 Oct 2019 11:53AM $0.645 $0.020 fallen by 96.90%
- Chairman's Address to Shareholders (Peak Acquisition) 14 Oct 2019 10:09AM $0.680 $0.020 fallen by 97.06%
- Althea Reaches 2329 Patients After Record Month 4 Oct 2019 8:27AM $0.620 $0.020 fallen by 96.77%
- Change in substantial holding 25 Sep 2019 5:18PM $0.735 $0.020 fallen by 97.28%
- Waiver of ASX Listing Rules 7.3.2 and 10.13.3 18 Sep 2019 10:58AM $0.770 $0.020 fallen by 97.40%

351 - 375 of 486 results

Page 15 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.